Search

everythinglearnresearchcommunity

for

Search:↓

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Some breast cancer chemotherapy can cause permanent hair loss.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

No cure exists for alopecia areata, and treatments are personalized.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Platelet-rich plasma and microneedling could potentially help hair regrowth in alopecia areata patients, but more research is needed.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

An elderly Chinese man lost all his hair after taking a new heart medication.

Non-invasive methods can effectively diagnose and manage alopecia areata.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

A woman's hair grew back after treatment for a rare hair loss caused by proton therapy.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.